This is not the most recent version of the article. View current version (6 MAY 2014)

Intervention Protocol

Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders

  1. Julie Regan1,*,
  2. Margaret Walshe2,
  3. Anne Murphy3,
  4. Barry P McMahon4,
  5. Tara Coughlan5

Editorial Group: Cochrane Upper Gastrointestinal and Pancreatic Diseases Group

Published Online: 11 JUL 2012

DOI: 10.1002/14651858.CD009968

How to Cite

Regan J, Walshe M, Murphy A, McMahon BP, Coughlan T. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009968. DOI: 10.1002/14651858.CD009968.

Author Information

  1. 1

    Adelaide and Meath Hospital, Trinity College Dublin, Department Speech & Language Therapy Department School of Clinical Medicine, Trinity College Dublin, Dublin, Ireland

  2. 2

    Trinity College Dublin, Clinical Speech and Language Studies, Dublin 2, Ireland

  3. 3

    Adelaide and Meath Hospital, AMNCH Library, Dublin, Ireland

  4. 4

    Adelaide and Meath Hospital, Trinity College Dublin, Medical Physics & Clinical Engineering, Dublin, Ireland

  5. 5

    Adelaide and Meath Hospital, Age Related Health Care, Dublin, Ireland

*Julie Regan, Department Speech & Language Therapy Department School of Clinical Medicine, Trinity College Dublin, Adelaide and Meath Hospital, Trinity College Dublin, Tallaght, Dublin 24, Dublin, Ireland. reganju@tcd.ie.

Publication History

  1. Publication Status: New
  2. Published Online: 11 JUL 2012

SEARCH

This is not the most recent version of the article. View current version (06 MAY 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To establish the efficacy and safety of botulinum toxin aimed at improving UOS dysfunction in people with non progressive and progressive  neurological disease.
  2. To provide the best evidence to inform clinical practice.
  3. To assist with future research planning.